INHIBITION OF PLASMINOGEN ACTIVATORS BY NATURALLY OCCURING INHIBITORS IN MAN = INHIBITION DES ACTIVATEURS DU PLASMINOGENE PAR LES INHIBITEURS DE FORMATION NATURELLE CHEZ L'HOMMEAOKI N; KAWANO T.1972; AMER. J. PHYSIOL.; U.S.A.; DA. 1972; VOL. 223; NO 6; PP. 1334-1337; BIBL. 27REF.Serial Issue

Fibrinolyse, nouveaux concepts: vésicules et cross-talk fibrinolytiques = Fibrinolysis, new concepts: fibrinolytic microvesicles and cross-talkPLAWINSKI, Laurent; DEJOUVENCEL, Tiphaine; ANGLES-CANO, Eduardo et al.Hématologie (Montrouge). 2011, Vol 17, Num 6, pp 423-434, issn 1264-7527, 12 p.Article

THE BINDING OF GLU- AND LYS-PLASMINOGENS TO FIBRIN AND THEIR SUBSEQUENT EFFECTS ON FIBRINOLYSISWHITAKER AN; ROWE EA; MASCI PP et al.1980; THROMB. RES.; ISSN 0049-3848; USA; DA. 1980; VOL. 19; NO 3; PP. 381-391; BIBL. 30 REF.Article

PHYSIOLOGICAL ACTIVATION OF THE HUMAN FIBRINOLYTIC SYSTEM. ISOLATION AND CHARACTERIZATION OF HUMAN PLASMINOGEN VARIANTS, CHICAGO I AND CHICAGO IIWOHL RC; SUMMARIA L; ROBBINS KC et al.1979; J. BIOL. CHEM.; USA; DA. 1979; VOL. 254; NO 18; PP. 9063-9069; BIBL. 29 REF.Article

Tissue plasminogen activator and urokinase mediate the binding of glu-plasminogen to plasma fibrin I: evidence for new binding sites in plasmin-degraded fibrin IHARPEL, P. C; TSUN-SAN CHANG; VERDERBER, E et al.The Journal of biological chemistry (Print). 1985, Vol 260, Num 7, pp 4432-4440, issn 0021-9258Article

ENZYMATIC PROPERTIES OF PLASMINS CONVERTED FROM ACID-TREATED AND NATIVE GLU- AND LYS-PLASMINOGENS BY UROKINASETAKADA A; TAKADA Y.1981; THROMB. RES.; ISSN 0049-3848; USA; DA. 1981; VOL. 21; NO 6; PP. 593-601; BIBL. 18 REF.Article

PLASMINOGEN ACTIVATOR IN CORNEA AND OTHER OCULAR TISSUES, DETECTED BY CULTURE METHODS = ACTIVATEUR DU PLASMINOGENE DANS LA CORNEE ET AUTRES TISSUS OCULAIRES DETECTES PAR DES METHODES DE CULTUREITOI M; KOTANI H.1972; JAP. J. OPHTHALMOL.; JAP.; DA. 1972; VOL. 16; NO 2; PP. 11-17; BIBL. 9 REF.Serial Issue

A METHOD FOR THE MEASUREMENT OF FIBRINOLYTIC ACTIVITY BASED ON ONE DIMENSIONAL DIFFUSION USING SMALL GLASS TUBES. II. WITH SPECIAL REFERENCE TO THE DIFFERENCES BETWEEN THE USE OF PLASMINOGEN-RICH FIBRINOGEN AND THAT OF PLASMINOGEN-FREE FIBRINOGEN AS THE SUBSTRATES.YASUKOUCHI T; FUJINE M; KOHN S et al.1977; THROMBOSIS AND HAEMOSTASIS; GERM.; DA. 1977; VOL. 37; NO 3; PP. 456-463; ABS. FR. ALLEM.; BIBL. 11 REF.Article

Kinetic analyses of the activation of Glu-plasminogen by urokinase in the presence of fibrin, fibrinogen or its degradation productsWATAHIKI, Y; TAKADA, Y; TAKADA, A et al.Thrombosis research. 1987, Vol 46, Num 1, pp 9-18, issn 0049-3848Article

Effect of Tisseel® on expression of tissue plasminogen activator and plasminogen activator inhibitor-1DIAMOND, Michael P; KRUGER, Michael; SAED, Ghassan M et al.Fertility and sterility. 2004, Vol 81, Num 6, pp 1657-1664, issn 0015-0282, 8 p.Article

Plasminogen and plasminogen activator assembly on the human endothelial cellSHIH, G. C; HAJJAR, K. A.Proceedings of the Society for Experimental Biology and Medicine. 1993, Vol 202, Num 3, pp 258-264, issn 0037-9727Article

Comparison of immunohistochemistry with immunoassay (ELISA) for the detection of components of the plasminogen activation system in human tumour tissueFERRIER, C. M; DE WITTE, H. H; STRAATMAN, H et al.British journal of cancer. 1999, Vol 79, Num 9-10, pp 1534-1541, issn 0007-0920Article

Involvement of plasminogen activator and plasminogen activator inhibitor type 1 in spermatogenesis, sperm capacitation, and fertilizationLIU, Yi-Xun.Seminars in thrombosis and hemostasis. 2007, Vol 33, Num 1, pp 29-40, issn 0094-6176, 12 p.Article

Evidence for an active fibrinolytic system in normal human bone marrowMCWILLIAM, N. A; ROBBIE, L. A; BARELLE, C. J et al.British journal of haematology. 1996, Vol 93, Num 1, pp 170-176, issn 0007-1048Article

Fibrinolysis during normal human pregnancy: complex inter-relationships between plasma levels of tissue plasminogen activator and inhibitors and the euglobulin clot lysis timeWRIGHT, J. G; COOPER, P; ASTEDT, B et al.British journal of haematology. 1988, Vol 69, Num 2, pp 253-258, issn 0007-1048Article

The influence of fibrinogen fragments on the kinetic parameters of the tissue-type plasminogen-activator-mediated activation of different forms of plasminogenNIEUWENHUIZEN, W; VOSKUILEN, M; VERMOND, A et al.European journal of biochemistry (Print). 1988, Vol 174, Num 1, pp 163-169, issn 0014-2956Article

Effects of tranexamic acid on the conversion of glu-plasminogen I and II to its lys-formsTAKADA, A; TAKADA, Y.Thrombosis research. 1985, Vol 40, Num 2, pp 171-179, issn 0049-3848Article

Kinetic analyses of the enhancement of the activities of t-PA induced by the presence of monoclonal antibody (C9-5)SUGAWARA, Y; TAKADA, Y; YAMAMOTO, K et al.Thrombosis research. 1988, Vol 50, Num 5, pp 637-646, issn 0049-3848Article

Sensitive and direct assays for functionally active plasminogen activators (tissue-type and urokinase-type) in plasmaMAHER MAHMOUD-ALEXANDRONI; HEATH, A. B; GAFFNEY, P. J et al.American journal of clinical pathology. 1989, Vol 92, Num 3, pp 308-314, issn 0002-9173, 7 p.Article

Mechanism of the synergistic effect between oversulfated chondroitin-6-sulfate and lysine or 6-aminohexanoic acid in enhancing the in-vitro activation of glutamic plasminogen by tissue plasminogen activator or urokinaseKOUEMO, Stella; MCMILLAN, Erinn; DOCTOR, Vasant et al.Blood coagulation & fibrinolysis. 2010, Vol 21, Num 5, pp 425-430, issn 0957-5235, 6 p.Article

Tissue-type plasminogen activator in somatostatin cells of rat pancreas and hypothalamusKRISTENSEN, P; NIELSEN, J. H; LARSSON, L.-I et al.Endocrinology (Philadelphia). 1987, Vol 121, Num 6, pp 2238-2244, issn 0013-7227Article

Comparison of kinetic parameters of the activation of glu-plasminogen by tissue plasminogen activator obtained from various sourcesTAKADA, A; SUGAWARA, Y; TAKADA, Y et al.Haemostasis. 1988, Vol 18, Num 2, pp 117-125, issn 0301-0147Article

New strategies in the development of thrombolytic agentsLIJNEN, H. R; COLLEN, D.Blut. 1988, Vol 57, Num 4, pp 147-162, issn 0006-5242Article

Inhibition in purified systems and in human plasma of chimaeric plasminogen activators consisting of the NH₂-terminal region of tissue-type plasminogen activator and the COOH-terminal region of urokinase-type plasminogen activatorLIJNEN, H. R; NELLES, L; VAN HOEF, B et al.Thrombosis and haemostasis. 1988, Vol 60, Num 2, pp 247-250, issn 0340-6245Article

The resistance of fibrin-stimulated tissue plasminogen activator to inactivation by a class PAI-2 inhibitor (minactivin)KIN-CHUEN LEUNG; BYATT, J. A; STEPHENS, R. W et al.Thrombosis research. 1987, Vol 46, Num 6, pp 755-766, issn 0049-3848Article